Development of antibody based biosensor kit for rapid detection of tuberculosis by using urine samples
Amrita Masanta1, Shikha Singh1*
1. Centre for Biotechnology, Siksha ‘O’ Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India. 1*corresponding author: Rama Devi Women’s University, Bhoinagar, Bhubaneswar, Odisha, India. *email: shikhsingh@gmail.com
Samples Total Proteins
Introduction Healthy Control -0.055±0.505 Tuberculosis (TB) stands one of the most infectious and highly contagious disease ever. Mild infection 0.765±0.631 Mainly cause by Mycobacterium tuberculosis, remains Acute infection 5.777±1.785 dormant state for many years. Chronic infection 6.693±1.766 Infection rate cross 10 million and mortality rate 1.7 million every year (WHO GLOBAL TB REPORT Fig: 1 Shows the total antigenic protein content (mg/ml) in normal and negative 2018). urine samples at different phases of TB infection. TB has been re-emerged globally as a result of the evolution of drug and multi drug resistant strains . Developing countries people are facing resource-poor settings that mainly outbreaks the TB transmission which results constantly increasing of mortality rate. Techniques like flowcytometry, radiometric detection, latex agglutination etc. hold their own set of imperfections. All above problems permit us to design a robust, highly sensitive & specific with accuracy diagnostic kit for initial detection of tuberculosis infection. Fig.2 Banding pattern of 12% SDS-PAGE Fig.3 Indirect ELISA shows the Methodology (A) Proteins indicate from positive urine deviation in absorbance at 450 nm samples of phase III; Molecular weight of as an activity of protein. standard protein is shown on left margin.
Sample collection (urine) and estimation of
antigens (Mycobacterium proteins) Fig.4 Analysis of Western blotting of antibody to pooled Separation of proteins by SDS-PAGE & antigen mycobacterial quantification by Indirect ELISA using TB antigenic proteins infected serum. from various phases of TB infection.
Immunoblotting and specific bands eluted from gel
and followed by tryptic digestion Work to be done Immunoblotting and gel tryptic in -solution digestion . Peptide analysis by MALDI TOF/MS Peptide analysis by MALDI TOF/MS. Peptide spectra analysis and protein identification. Development of diagnostic immuno chromatographic kit using antibody and its standardization. Peptide spectra analysis and protein identification Conclusion Acknowledgements Biosensing technology have 1. Department of Science and Results potential for early detection of Technology, New Delhi, India. TB infection. 2. Centre for Biotechnology, Siksha ‘O’ Among the 100 urine samples, 25 samples were Effective for developing Anusandhan , Bhubaneswar, Odisha, positive (pulmonary TB), 45 samples were negative countries with resource-poor India. control & 30 samples were healthy control and protein settings. estimation was carried , shown in fig.1. It can be cost effective , high References SDS-PAGE was done with all urine samples, banding sensitivity, reliability (no false P. Nahid, M. Pai and P. C. Hopewell, pattern was shown in fig.2. +ve), portability &disposability. Proc. Am. Thorac. Soc., 2006, 3, 103. Identification of antigenic protein was done by ELISA A progress towards TB J. C. Palomino, A. Martin, M. and activity of protein was shown in fig. 3. elimination can be possible by Camacho, H. Guerra, J. Swings and F. Immunoblotting was performed and the response of biosensors. Portaels, Antimicrob. Agents Ab-Ag was seen against ranging from MW of 10-120 Chemother., 2002, 46(8), 2720–2722. kDa shown in fig.4. The Ab response was high against the antigens with MW of 35 kDa, 66 kDa, 110 kDa and seen additional bands of reactivity, including 14 kDa, 16 kDa, 190 kDa and 110 kDa. “INSPIRE Fellowship Review Meet” organized by Kalinga Institute of Industrial Technology (KIIT), Bhubaneswar, Odisha, India, Pin: 751024 6th, 7th and 8th June 2019 .
2020 - Detecting Ethambutol Resistance in Mycobacterium Tuberculosis Isolates in China A Comparison Between Phenotypic Drug Susceptibility Testing Methods and DNA Sequencing of embAB
Robert R. Rich, Thomas A. Fleisher, Harry W. Schroeder JR., Cornelia M. Weyand, David B. Corry, Jennifer M. Puck - Clinical Immunology - Principles and Practice-Elsevier (2022)